Clinical Trial Update: A Study of ZEN003694 in People With Squamous Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ZEN003694 in patients with squamous cell carcinoma of the lung is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• ZEN003694

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Squamous Cell Lung Cancer | Phase 2 | Status: RECRUITING